[1]
|
Gianesello, L., Del Prete, D., Anglani, F., et al. (2021) Genetics and Phenotypic Heterogeneity of Dent Disease: The Dark Side of the Moon. Human Genetics, 140, 401-421. https://doi.org/10.1007/s00439-020-02219-2
|
[2]
|
姚勇. 儿童Dent病及临床相关问题[J]. 中华实用儿科临床杂志, 2018, 33(17): 1281-1286.
|
[3]
|
Smith, A.J. and Lippiat, J.D. (2010) Direct Endosomal Acidification by the Outwardly Rectifying CLC-5 Cl(−)/H(+) Exchanger. The Journal of Physiology, 588, 2033-2045. https://doi.org/10.1113/jphysiol.2010.188540
|
[4]
|
Bignon, Y., Alekov, A., Frachon, N., et al. (2018) A Novel CLCN5 Pathogenic Mutation Supports Dent Disease with Normal Endosomal Acidification. Human Mutation, 39, 1139-1149. https://doi.org/10.1002/humu.23556
|
[5]
|
Satoh, N., Yamada, H., Yamazaki, O., et al. (2016) A Pure Chloride Channel Mutant of CLC-5 Causes Dent’s Disease via Insufficient V-ATPase Activation. Pflügers Archiv, 468, 1183-1196. https://doi.org/10.1007/s00424-016-1808-7
|
[6]
|
Novarino, G., Weinert, S., Rickheit, G., et al. (2010) Endosomal Chloride-Proton Exchange Rather than Chloride Conductance Is Crucial for Renal Endocytosis. Science, 328, 1398-1401. https://doi.org/10.1126/science.1188070
|
[7]
|
Gianesello, L., Ceol, M., Bertoldi, L., et al. (2020) Genetic Analyses in Dent Disease and Characterization of CLCN5 Mutations in Kidney Biop-sies. International Journal of Molecular Sciences, 21, Article No. 516.
https://doi.org/10.3390/ijms21020516
|
[8]
|
Zhai, P., Lv, W., Yang, X., et al. (2022) Renal Expression of CLC-5 and Megalin/Cubilin in Dent-1 Disease with Nonsense Mutations of CLCN5 Gene. Pediatric and Developmental Pa-thology, 25, 397-403.
https://doi.org/10.1177/10935266211065554
|
[9]
|
Lee, A., Slattery, C., Nikolic-Paterson, D.J., et al. (2015) Chlo-ride Channel ClC-5 Binds to Aspartyl Aminopeptidase to Regulate Renal Albumin Endocytosis. American Journal of Physiology-Renal Physiology, 308, F784-F792.
https://doi.org/10.1152/ajprenal.00322.2014
|
[10]
|
Piwon, N., Günther, W., Schwake, M., et al. (2000) ClC-5 Cl− Channel Disruption Impairs Endocytosis in a Mouse Model for Dent’s Disease. Nature, 408, 369-373. https://doi.org/10.1038/35042597
|
[11]
|
Silva, I.V., Cebotaru, V., Wang, H., et al. (2003) The ClC-5 Knockout Mouse Model of Dent’s Disease Has Renal Hypercalciuria and Increased Bone Turnover. Journal of Bone and Mineral Research, 18, 615-623.
https://doi.org/10.1359/jbmr.2003.18.4.615
|
[12]
|
Silva, I.V., Blaisdell, C.J., Guggino, S.E., et al. (2000) PTH Reg-ulates Expression of ClC-5 Chloride Channel in the Kidney. American Journal of Physiology-Renal Physiology, 278, F238-F245.
https://doi.org/10.1152/ajprenal.2000.278.2.F238
|
[13]
|
Oltrabella, F., Pietka, G., Ramirez, I.B., et al. (2015) The Lowe Syndrome Protein OCRL1 Is Required for Endocytosis in the Zebrafish Pronephric Tubule. PLOS Genetics, 11, e1005058. https://doi.org/10.1371/journal.pgen.1005058
|
[14]
|
Suruda, C., Tsuji, S., Yamanouchi, S., et al. (2017) Decreased Urinary Excretion of the Ectodomain form of Megalin (A-megalin) in Children with OCRL Gene Mutations. Pediatric Nephrology, 32, 621-625.
https://doi.org/10.1007/s00467-016-3535-x
|
[15]
|
Inoue, K., Balkin, D.M., Liu, L., et al. (2017) Kidney Tubular Ablation of Ocrl/Inpp5b Phenocopies Lowe Syndrome Tubulopathy. Journal of the American Society of Nephrology, 28, 1399-1407.
https://doi.org/10.1681/ASN.2016080913
|
[16]
|
Festa, B.P., Berquez, M., Gassama, A., et al. (2019) OCRL Defi-ciency Impairs Endolysosomal Function in a Humanized Mouse Model for Lowe Syndrome and Dent Disease. Human Molecular Genetics, 28, 1931-1946.
https://doi.org/10.1093/hmg/ddy449
|
[17]
|
Wu, G., Zhang, W., Na, T., et al. (2012) Suppression of Intestinal Cal-cium Entry Channel TRPV6 by OCRL, a Lipid Phosphatase Associated with Lowe Syndrome and Dent Disease. The American Journal of Physiology-Cell Physiology, 302, C1479-C1491. https://doi.org/10.1152/ajpcell.00277.2011
|
[18]
|
Anglani, F., Terrin, L., Brugnara, M., et al. (2018) Hypercalciuria and Nephrolithiasis: Expanding the Renal Phenotype of Donnai-Barrow Syndrome. Clinical Genetics, 94, 187-188. https://doi.org/10.1111/cge.13242
|
[19]
|
Jouret, F., Bernard, A., Hermans, C., et al. (2007) Cystic Fibrosis Is Asso-ciated with a Defect in Apical Receptor-Mediated Endocytosis in Mouse and Human Kidney. Journal of the American Society of Nephrology, 18, 707-718.
https://doi.org/10.1681/ASN.2006030269
|
[20]
|
Zhang, Y., Fang, X., Xu, H., et al. (2017) Genetic Analysis of Dent’s Disease and Functional Research of CLCN5 Mutations. DNA and Cell Biology, 36, 1151-1158. https://doi.org/10.1089/dna.2017.3731
|
[21]
|
Wojciechowski, D., Kovalchuk, E., Yu, L., et al. (2018) Barttin Regu-lates the Subcellular Localization and Posttranslational Modification of Human Cl(−)/H(+) Antiporter ClC-5. Frontiers in Physiology, 9, Article No. 1490.
https://doi.org/10.3389/fphys.2018.01490
|
[22]
|
Drosataki, E., Maragkou, S., Dermitzaki, K., et al. (2022) Dent-2 Disease with a Bartter-Like Phenotype Caused by the Asp631Glu Mutation in the OCRL Gene. BMC Nephrology, 23, Article No. 182.
https://doi.org/10.1186/s12882-022-02812-9
|
[23]
|
Sakakibara, N., Nagano, C., Ishiko, S., et al. (2020) Comparison of Clinical and Genetic Characteristics between Dent Disease 1 and Dent Disease 2. Pediatric Nephrology, 35, 2319-2326. https://doi.org/10.1007/s00467-020-04701-5
|
[24]
|
De Matteis, M.A., Staiano, L., Emma, F., et al. (2017) The 5-Phosphatase OCRL in Lowe Syndrome and Dent Disease 2. Nature Reviews Nephrology, 13, 455-470. https://doi.org/10.1038/nrneph.2017.83
|
[25]
|
Zaniew, M., Bökenkamp, A., Kolbuc, M., et al. (2018) Long-Term Renal Outcome in Children with OCRL Mutations: Retrospective Analysis of a Large International Cohort. Nephrology Dialysis Transplantation, 33, 85-94.
|
[26]
|
Ye, Q., Shen, Q., Rao, J., et al. (2020) Multicenter Study of the Clinical Fea-tures and Mutation Gene Spectrum of Chinese Children with Dent Disease. Clinical Genetics, 97, 407-417. https://doi.org/10.1111/cge.13663
|
[27]
|
Hichri, H., Rendu, J., Monnier, N., et al. (2011) From Lowe Syndrome to Dent Disease: Correlations between Mutations of the OCRL1 Gene and Clinical and Biochemical Phenotypes. Human Mutation, 32, 379-388.
https://doi.org/10.1002/humu.21391
|
[28]
|
Becker-Cohen, R., Rinat, C., Ben-Shalom, E., et al. (2012) Vitamin A Deficiency Associated with Urinary Retinol Binding Protein Wasting in Dent’s Disease. Pediatric Nephrology, 27, 1097-1102.
https://doi.org/10.1007/s00467-012-2121-0
|
[29]
|
Marzuillo, P., Piccolo, V., Mascolo, M., et al. (2018) Patients Af-fected by Dent Disease 2 Could Be Predisposed to Hidradenitis Suppurativa. The Journal of the European Academy of Dermatology and Venereology, 32, e309-e311.
https://doi.org/10.1111/jdv.14860
|
[30]
|
Akil, I., Ozen, S., Kandiloglu, A.R., et al. (2010) A Patient with Bartter Syndrome Accompanying Severe Growth Hormone Deficiency and Focal Segmental Glomerulosclerosis. Clinical and Experimental Nephrology, 14, 278-282.
https://doi.org/10.1007/s10157-009-0262-7
|
[31]
|
Okamoto, T., Tajima, T., Hirayama, T., et al. (2012) A Patient with Dent Disease and Features of Bartter Syndrome Caused by a Novel Mutation of CLCN5. European Journal of Pe-diatrics, 171, 401-404.
https://doi.org/10.1007/s00431-011-1578-3
|
[32]
|
Platt, C., Jadresic, L., Dudley, J., et al. (2014) Dent’s Disease Complicated by an Acute Budd-Chiari Syndrome. BMJ Case Reports, 2014, bcr2013200937. https://doi.org/10.1136/bcr-2013-200937
|
[33]
|
van Zaane, B., Stuijver, D.J., Squizzato, A., et al. (2013) Arterial and Venous Thrombosis in Endocrine Diseases. Seminars in Thrombosis and Hemostasis, 39, 489-495. https://doi.org/10.1055/s-0033-1343889
|
[34]
|
Wang, X., Anglani, F., Beara-Lasic, L., et al. (2016) Glomerular Pa-thology in Dent Disease and Its Association with Kidney Function. Clinical Journal of the American Society of Nephrol-ogy, 11, 2168-2176.
https://doi.org/10.2215/CJN.03710416
|
[35]
|
Ceol, M., Tiralongo, E., Baelde, H.J., et al. (2012) Involvement of the Tubular ClC-Type Exchanger ClC-5 in Glomeruli of Human Proteinuric Nephropathies. PLOS ONE, 7, e45605. https://doi.org/10.1371/journal.pone.0045605
|
[36]
|
Preston, R., Naylor, R.W., Stewart, G., et al. (2020) A Role for OCRL in Glomerular Function and Disease. Pediatric Nephrology, 35, 641-648. https://doi.org/10.1007/s00467-019-04317-4
|
[37]
|
Günthner, R., Wagner, M., Thurm, T., et al. (2018) Identification of Co-Occurrence in a Patient with Dent’s Disease and ADA2-Deficiency by Exome Sequencing. Gene, 649, 23-26. https://doi.org/10.1016/j.gene.2018.01.060
|
[38]
|
Yamamura, T., Nozu, K., Minamikawa, S., et al. (2019) Compari-son between Conventional and Comprehensive Sequencing Approaches for Genetic Diagnosis of Alport Syndrome. Mo-lecular Genetics & Genomic Medicine, 7, e883.
https://doi.org/10.1002/mgg3.883
|
[39]
|
Blanchard, A., Curis, E., Guyon-Roger, T., et al. (2016) Observations of a Large Dent Disease Cohort. Kidney International, 90, 430-439. https://doi.org/10.1016/j.kint.2016.04.022
|
[40]
|
张宏博, 黄建萍. 药物治疗Dent病15例的临床疗效[J]. 中华实用儿科临床杂志, 2016(3): 226-230.
|
[41]
|
张宏文, 王芳. Dent病高钙尿症和蛋白尿药物治疗的临床观察[J]. 中国生育健康杂志, 2016, 27(4): 324-327.
|
[42]
|
Deng, H., Zhang, Y., Xiao, H., et al. (2020) Phenotypic Spectrum and Antialbuminuric Response to Angiotensin Converting En-zyme Inhibitor and Angiotensin Receptor Blocker Therapy in Pediatric Dent Disease. Molecular Genetics & Genomic Medicine, 8, e1306. https://doi.org/10.1002/mgg3.1306
|
[43]
|
Cebotaru, V., Kaul, S., Devuyst, O., et al. (2005) High Citrate Diet Delays Progression of Renal Insufficiency in the ClC-5 Knockout Mouse Model of Dent’s Disease. Kidney International, 68, 642-652.
https://doi.org/10.1111/j.1523-1755.2005.00442.x
|
[44]
|
Santucci, L., Candiano, G., Anglani, F., et al. (2016) Urine Proteome Analysis in Dent’s Disease Shows High Selective Changes Potentially Involved in Chronic Renal Damage. Journal of Proteomics, 130, 26-32.
https://doi.org/10.1016/j.jprot.2015.08.024
|
[45]
|
Gabriel, S.S., Belge, H., Gassama, A., et al. (2017) Bone Marrow Transplantation Improves Proximal Tubule Dysfunction in a Mouse Model of Dent Disease. Kidney International, 91, 842-855. https://doi.org/10.1016/j.kint.2016.11.016
|
[46]
|
Berquez, M., Gadsby, J.R., Festa, B.P., et al. (2020) The Phosphoinositide 3-Kinase Inhibitor Alpelisib Restores Actin Organization and Improves Proximal Tubule Dysfunction in Vitro and in a Mouse Model of Lowe Syndrome and Dent Disease. Kidney International, 98, 883-896. https://doi.org/10.1016/j.kint.2020.05.040
|
[47]
|
Liu, J., Sadeh, T.T., Lippiat, J.D., et al. (2021) Small Molecules Restore the Function of Mutant CLC5 Associated with Dent Disease. Journal of Cellular and Molecular Medicine, 25, 1319-1322. https://doi.org/10.1111/jcmm.16091
|